DDIC has established collaborative relationship with regional organizations with complementary expertise in drug development. This partnership enables seamless transition of drug candidates from lab to market.
DDIC: Drug Development and Innovation Center; AITF: Alberta Innovates Technology Futures; CCI: Cross Cancer Institute; NACTRC: Northern Alberta Clinical Trials Research Center; CARE: Complementary and Alternative Research and Education
DDIC has close linkages with global organizations such as United States Pharmacopoeia (USP), American Association of Pharmaceutical Scientists (AAPS), and universities and companies in South Korea, China, Brazil and Germany.
DDIC has successfully developed products for start-up companies, provided regulatory guidance to others and has been instrumental in development and approval of various drug products discovered by university researchers. Some of the past and present collaborators of the Centre include: Alberta Rhodiola Rosea Growers Organization (ARRGO), IgY Inc., Alberta based Pharmaceutical and NHP companies and United States Pharmacopoeia (USP).